The global adhesion barriers market was valued at US$ 536.5 Mn in 2017 and expected to reach US$ 980.2 Mn by 2026, expanding at a CAGR of 6.9% from 2018 to 2026.
Market Insights:
Adhesion formation is among the most common postoperative complications, occurring in over 60% of patients after gynecological surgery. The major strategies adopted for adhesion prevention in surgery is aiming at the optimization of the surgical approach and the use of adhesion barriers. Adhesion barriers discussed in this report refer to the intraperitoneal barriers.
Adhesion barriers effectively prevent the formation of tissue and organ adhesion commonly occurring after surgical intervention. Tissue and organ adhesion results in common complications such as infertility, bowel obstruction, and chronic pain to the patients. Adhesion barriers are classified into types namely synthetic barriers and natural barriers. Natural adhesion barriers include collagen and protein-based barriers; whereas synthetic adhesion barriers are further classified into hyaluronic acid, polyethylene glycol (peg), regenerated cellulose and others. Appropriate use of adhesion barriers not just avoid the risk of tissue adhesion, but also consequently reduce the need for follow-up intervention, therefore reducing the treatment costs. On the other hand, high costs of adhesion barriers is a key challenge restraining the widespread adoption of these products in the field of surgical approach.
The global adhesion barriers market is anticipated to grow at a steady CAGR of 6.9% during the forecast period from 2018 to 2026. Growing geriatric population, increasing the prevalence of chronic diseases and the need for surgical intervention in this group forms one of the key market drivers. Among the various product types, the demand for synthetic adhesion barriers is observed to be the highest, therefore gathering the larger revenue share as against natural barriers. Better efficacy and cost-effectiveness of synthetic barriers form a key factor supporting the dominance of this segment. Additionally, among the various surgical applications, adhesion barriers find the highest consumption in gynecological surgeries. High incidence of tissue and organ adhesion following hysterectomies and pelvic cancers is a key determinant of this trend.
Key Market Movements:
This product will be delivered within 2 business days.
Market Insights:
Adhesion formation is among the most common postoperative complications, occurring in over 60% of patients after gynecological surgery. The major strategies adopted for adhesion prevention in surgery is aiming at the optimization of the surgical approach and the use of adhesion barriers. Adhesion barriers discussed in this report refer to the intraperitoneal barriers.
Adhesion barriers effectively prevent the formation of tissue and organ adhesion commonly occurring after surgical intervention. Tissue and organ adhesion results in common complications such as infertility, bowel obstruction, and chronic pain to the patients. Adhesion barriers are classified into types namely synthetic barriers and natural barriers. Natural adhesion barriers include collagen and protein-based barriers; whereas synthetic adhesion barriers are further classified into hyaluronic acid, polyethylene glycol (peg), regenerated cellulose and others. Appropriate use of adhesion barriers not just avoid the risk of tissue adhesion, but also consequently reduce the need for follow-up intervention, therefore reducing the treatment costs. On the other hand, high costs of adhesion barriers is a key challenge restraining the widespread adoption of these products in the field of surgical approach.
The global adhesion barriers market is anticipated to grow at a steady CAGR of 6.9% during the forecast period from 2018 to 2026. Growing geriatric population, increasing the prevalence of chronic diseases and the need for surgical intervention in this group forms one of the key market drivers. Among the various product types, the demand for synthetic adhesion barriers is observed to be the highest, therefore gathering the larger revenue share as against natural barriers. Better efficacy and cost-effectiveness of synthetic barriers form a key factor supporting the dominance of this segment. Additionally, among the various surgical applications, adhesion barriers find the highest consumption in gynecological surgeries. High incidence of tissue and organ adhesion following hysterectomies and pelvic cancers is a key determinant of this trend.
Key Market Movements:
- The increasing pool of the geriatric population, and a high risk of chronic diseases demanding surgical intervention
- The growing incidence of gynecological diseases and uterine cancers demanding hysterectomies and other forms of surgeries
- Increasing awareness about the benefits from adhesion barriers in preventing cost burden on treatments
- Growing market entry of players from the developed markets to the emerging regions and the Asia Pacific and Latin America
- Proliferating medical tourism in Latin America and the Asia Pacific urging the uptake of advanced surgical products and approaches
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Adhesion Barriers Market Portraiture
2.2. Global Adhesion Barriers Market, by Product Type, 2017 (US$ Mn)
2.3. Global Adhesion Barriers Market, by Formulation, 2017 (US$ Mn)
2.4. Global Adhesion Barriers Market, by Surgical Application, 2017 (US$ Mn)
2.5. Global Adhesion Barriers Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Adhesion Barriers Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Adhesion Barriers Market, by Key Players, 2017
Chapter 4. Global Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Synthetic Barriers
4.2.1. Hyaluronic Acid
4.2.2. Polyethylene Glycol (PEG)
4.2.3. Regenerated Cellulose
4.2.4. Others
4.3. Natural Barriers
4.3.1. Fibrin
4.3.2. Collagen & Protein
Chapter 5. Global Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. Gel
5.3. Liquid
5.4. Film
Chapter 6. Global Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
6.1. Overview
6.2. Gynecology
6.3. Abdominal General Surgery
6.4. Cardiovascular
6.5. Neurology
6.6. Orthopedic
6.7. Urology
6.8. Others
Chapter 7. Global Adhesion Barriers Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
7.2.1. North America Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
7.2.2. North America Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
7.2.3. North America Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
7.2.4. North America Adhesion Barriers Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Adhesion Barriers Market, 2016 – 2026 (US$ Mn)
7.3.1. Europe Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
7.3.2. Europe Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
7.3.3. Europe Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
7.3.4. Europe Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Adhesion Barriers Market, 2016 – 2026 (US$ Mn)
7.4.1. Asia Pacific Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
7.4.2. Asia Pacific Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
7.4.3. Asia Pacific Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
7.4.4. Asia Pacific Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America Adhesion Barriers Market, 2016 – 2026 (US$ Mn)
7.5.1. Latin America Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
7.5.2. Latin America Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
7.5.3. Latin America Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
7.5.4. Latin America Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa Adhesion Barriers Market, 2016 – 2026 (US$ Mn)
7.6.1. Middle East & Africa Adhesion Barriers Market, by Product Type, 2016 - 2026 (US$ Mn)
7.6.2. Middle East & Africa Adhesion Barriers Market, by Formulation, 2016 - 2026 (US$ Mn)
7.6.3. Middle East & Africa Adhesion Barriers Market, by Surgical Application, 2016 - 2026 (US$ Mn)
7.6.4. Middle East & Africa Adhesion Barriers Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of Middle East & Africa
Chapter 8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Anika Therapeutics
8.3. C. R. Bard, Inc.
8.4. FzioMed
8.5. Baxter International
8.6. Sanofi-Aventis U.S. LLC
8.7. W. L. Gore & Associates
8.8. MAST Biosurgery, Inc.
8.9. Integra LifeSciences Holdings Corporation
8.10. Becton Dickinson and Company
8.11. Atrium Medical Corporation
List of Figures
FIG 1. Adhesion Barriers Market: Research Methodology
FIG 2. Market Size Estimation – Top Down & Bottom up Approach
FIG 3. Adhesion Barriers: Market Segmentation
FIG 4. Global Adhesion Barriers Market, by Product Type, 2017 (US$ Mn)
FIG 5. Global Adhesion Barriers Market, by Formulation, 2017 (US$ Mn)
FIG 6. Global Adhesion Barriers Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Adhesion Barriers Market, by Key Players, 2017
FIG 9. Global Hyaluronic Acid Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 10. Global Polyethylene Glycol (PEG) Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 11. Global Regenerated Cellulose Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 12. Global Other Synthetic Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 13. Global Fibrin Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 14. Global Collagen and Protein Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 15. Global Gel Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 16. Global Liquid Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 17. Global Film Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 18. Global Adhesion Barriers Market for Gynecology, 2016 - 2026 (US$ Mn)
FIG 19. Global Adhesion Barriers Market for Abdominal General Surgery, 2016 - 2026 (US$ Mn)
FIG 20. Global Adhesion Barriers Market for Cardiovascular, 2016 - 2026 (US$ Mn)
FIG 21. Global Adhesion Barriers Market for Neurology, 2016 - 2026 (US$ Mn)
FIG 22. Global Adhesion Barriers Market for Orthopedics, 2016 - 2026 (US$ Mn)
FIG 23. Global Adhesion Barriers Market for Urology, 2016 - 2026 (US$ Mn)
FIG 24. Global Adhesion Barriers Market for Other Surgical Applications, 2016 - 2026 (US$ Mn)
FIG 25. U.S. Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 26. Canada Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 27. U.K. Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 28. Germany Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 29. Rest of Europe Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 30. China Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 31. Japan Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 32. India Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 33. Rest of Asia Pacific Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 34. Brazil Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 35. Mexico Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 36. Rest of Latin America Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 37. GCC Adhesion Barriers Market, 2016 - 2026 (US$ Mn)
FIG 38. Rest of Middle East and Africa Adhesion Barriers Market, 2016 - 2026 (US$ Mn)List of Tables
TABLE 1 Global Adhesion Barriers Market Portraiture
TABLE 2 Global Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Synthetic Adhesion Barriers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Natural Adhesion Barriers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 6 Global Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 7 Global Adhesion Barriers Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 8 North America Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 10 North America Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 11 North America Adhesion Barriers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 15 Europe Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America Adhesion Barriers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa Adhesion Barriers Market, by Product Type, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa Adhesion Barriers Market, by Formulation, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East and Africa Adhesion Barriers Market, by Surgical Application, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East and Africa Adhesion Barriers Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 28 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Anika Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 C. R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 FzioMed: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Baxter International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Sanofi-Aventis U.S. LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 W. L. Gore & Associates: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 MAST Biosurgery, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Integra LifeSciences Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Atrium Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Companies Mentioned
- Johnson & Johnson
- Anika Therapeutics
- C. R. Bard, Inc.
- FzioMed
- Baxter International
- Sanofi-Aventis U.S. LLC
- W. L. Gore & Associates
- MAST Biosurgery, Inc.
- Integra LifeSciences Holdings Corporation
- Becton Dickinson and Company
- Atrium Medical Corporation
